Key terms

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BMY news

Nov 19 7:19am ET Truist Financial Reaffirms Their Buy Rating on Bristol-Myers Squibb (BMY) by TipRanks Nov 18 9:05am ET Wells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY) by TipRanks Nov 17 9:50am ET Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG) by TipRanks Nov 17 9:40am ET Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG) by TipRanks Nov 15 2:40pm ET Buy/Sell: Wall Street’s top 10 stock calls this week by TipRanks Nov 15 8:30am ET Bristol Myers announces CHMP opinion recommending approval of Opdivo plus Yervoy by TipRanks Nov 15 7:06am ET Bristol Myers receives positive CHMP opinion for repotrectinib by TipRanks Nov 14 6:50pm ET Wolfe starts Bristol Myers at Peer Perform, sees potential comeback story by TipRanks Nov 14 4:16pm ET Bristol Myers initiated with a Peer Perform at Wolfe Research by TipRanks Nov 13 12:15pm ET Bristol Myers Squibb put volume heavy and directionally bearish by TipRanks Nov 12 12:05pm ET Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz by TipRanks Nov 12 9:45am ET Bristol Myers price target raised to $61 from $57 at BMO Capital by TipRanks Nov 12 9:45am ET Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls by TipRanks Nov 12 7:31am ET Bristol Myers price target raised to $39 from $36 at Morgan Stanley by TipRanks Nov 12 7:31am ET AbbVie price target lowered to $224 from $231 at Morgan Stanley by TipRanks Nov 12 6:20am ET Leerink upgrades Bristol to Outperform after AbbVie schizophrenia failure by TipRanks Nov 12 6:05am ET Bristol Myers price target raised to $60 from $55 at Citi by TipRanks Nov 12 6:05am ET Bristol Myers upgraded to Outperform from Market Perform at Leerink by TipRanks Nov 11 11:35am ET Evercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive by TipRanks Nov 11 11:10am ET AbbVie under pressure as schizophrenia drug fails two trials by TipRanks Nov 11 10:35am ET Leerink sees AbbVie’s trial results as ‘clear positive’ for Bristol Myers by TipRanks Nov 11 10:15am ET JPMorgan sees AbbVie off about 10%, Bristol up 10%-15% on emraclidine news by TipRanks Nov 11 10:05am ET AbbVie ‘pain’ is Bristol Myers ‘gain’ after emraclidine fails, says Truist by TipRanks Nov 11 9:55am ET Early notable gainers among liquid option names on November 11th by TipRanks Nov 11 9:50am ET Bristol Myers rises 11.6% by TipRanks Nov 11 9:45am ET Bristol Myers rises, AbbVie sinks after schizophrenia trials miss targets by TipRanks Nov 05 7:50am ET Analysts Conflicted on These Healthcare Names: Bristol-Myers Squibb (BMY) and Envista Holdings (NVST) by TipRanks Nov 05 1:40am ET Analysts’ Top Healthcare Picks: Bristol-Myers Squibb (BMY), Agios Pharma (AGIO) by TipRanks Nov 05 1:35am ET Bristol-Myers Squibb: Hold Rating Maintained Amid Positive Clinical Trials and Long-term EPS Concerns by TipRanks Nov 01 3:11pm ET Bristol-Myers Squibb’s (NYSE:BMY) Schizophrenia Drug Sees Positive Results by TipRanks Nov 01 8:36am ET Jefferies Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY) by TipRanks
Nov 22 11:23am ET Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug by Zacks Nov 22 6:20am ET Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now? by Zacks Nov 20 9:00am ET Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It by Zacks Nov 15 6:20am ET Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar? by Zacks Nov 14 6:20am ET Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? by Zacks Nov 13 7:48am ET Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus by Zacks Nov 13 6:20am ET Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now? by Zacks Nov 12 6:40pm ET 3 Stocks Seeing Insider Buys: CNC, PFE, BMY by Zacks Nov 12 9:30am ET AbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains by Zacks Nov 11 1:50pm ET Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell? by Zacks Nov 07 6:20am ET Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar? by Zacks Nov 07 6:20am ET Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar? by Zacks Nov 06 9:00am ET Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know by Zacks Nov 01 9:17am ET Company News for Nov 1, 2024 by Zacks Nov 01 6:20am ET Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now? by Zacks Oct 31 11:10am ET Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View by Zacks Oct 31 10:55am ET Initial Claims Lower-Than-Expected by Zacks Oct 31 10:32am ET Un-spooky Halloween: PCE, Jobless Claims Tame by Zacks Oct 31 9:30am ET Compared to Estimates, Bristol Myers (BMY) Q3 Earnings: A Look at Key Metrics by Zacks Oct 31 8:10am ET Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates by Zacks Oct 30 6:36pm ET Markets Give Back Gains as Hovering Continues by Zacks Oct 30 6:20am ET Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar? by Zacks Oct 29 11:21am ET Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase by Zacks Oct 28 3:00pm ET Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? by Zacks Oct 28 1:59pm ET Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings? by Zacks Oct 28 12:06pm ET Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? by Zacks Oct 28 10:01am ET Myriad Genetics (MYGN) Earnings Expected to Grow: Should You Buy? by Zacks Oct 28 9:16am ET Curious about Bristol Myers (BMY) Q3 Performance? Explore Wall Street Estimates for Key Metrics by Zacks Oct 24 5:45pm ET Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know by Zacks Oct 24 10:01am ET Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for by Zacks Oct 23 9:00am ET Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock by Zacks

BMY Financials

1-year income & revenue

Key terms

BMY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BMY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Target expects a sluggish holiday season.
David Paul Morris/Bloomberg/Getty Images
Target sounds the alarm bell on holiday shopping
Investors piled into safe havens like gold and US debt as tensions rose in Europe. Gold prices jumped on Tuesday and US Treasury rates dipped.
Angela Weiss/AFP/Getty Images
Stocks shrug off concerns about heightened US-Russia tensions
A lone shopper places items in her cart in the frozen food aisle of a Walmart store Thursday, Nov. 14, 2024, in Englewood, Colo.
David Zalubowski/AP
As Americans bargain shop, six-figure earners flock to Walmart
NEW YORK, NEW YORK - JULY 07: Bikes with Grubhub bags sit on the street on July 07, 2023 in New York City. Grubhub, DoorDash and Uber Eats sued the City of New York on July 6th in order to block its new minimum pay rules for food delivery workers. (Photo by Leonardo Munoz/VIEWpress)
Leonardo Munoz/VIEWpress/Getty Images
Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion